Table 2.
Variable | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (years) | ||||
<65 | 1 | — | ||
≥65 | 0.819 (0.594–1.128) | 0.222 | ||
Gender | ||||
Female | 1 | — | ||
Male | 1.210 (0.878–1.669) | 0.245 | ||
Smoking | ||||
No | 1 | — | ||
Yes | 1.221 (0.838–1.778) | 0.298 | ||
BMI | 0.967 (0.909–1.028) | 0.277 | ||
eGFR (mL/min) | ||||
<60 | 1 | — | ||
>60 | 1.347 (0.757–2.396) | 0.312 | ||
Hemodialysis | ||||
No | 1 | — | 1 | — |
Yes | 1.603 (0.990–2.595) | 0.055 | 1.791 (0.988–3.244) | 0.055 |
Chinese herbal medicine use | ||||
No | 1 | — | 1 | — |
Yes | 1.851 (1.012–3.386) | 0.046* | 1.387 (0.731–2.632) | 0.316 |
Hypertension | ||||
No | 1 | — | ||
Yes | 1.292 (0.868–1.922) | 0.207 | ||
DM | ||||
No | 1 | — | 1 | — |
Yes | 1.953 (1.241–3.074) | 0.004* | 1.821 (1.152–2.878) | 0.010* |
Residency | ||||
Nonarsenic | 1 | — | ||
Arsenic | 0.775 (0.247–2.434) | 0.662 | ||
OP method | ||||
Transperitoneal | 1 | — | ||
Retroperitoneal | 1.097 (0.674–1.786) | 0.708 | ||
OP method | ||||
Open | 1 | — | ||
Laparoscopy | 1.420 (0.868–2.323) | 0.162 | ||
Grade | ||||
Low | 1 | — | ||
High | 0.994 (0.705–1.402) | 0.974 | ||
Ureteral involvement | ||||
No | 1 | — | 1 | — |
Yes | 1.639 (1.189–2.260) | 0.003* | 1.838 (1.233–2.741) | 0.003* |
Multiplicity | ||||
No | 1 | — | ||
Yes | 1.499 (0.953–2.356) | 0.080 | ||
T stage | ||||
Ta, 1 | 1 | — | ||
T2 | 1.135 (0.727–1.771) | 0.578 | ||
T3, 4 | 0.914 (0.610–1.368) | 0.661 | ||
Tis | 2.110 (0.770–5.785) | 0.147 | ||
N stage | ||||
N0 | 1 | — | ||
N1, 2, 3 | 0.394 (0.125–1.239) | 0.111 |
BMI: body mass index, DM: diabetes mellitus, HR: Hazard ratio, and CI: confidence interval.
*Significant difference, P < 0.05.